Abstract
An agent that clears disease-associated amyloid aggregates from the brains of patients with Alzheimer's disease does not alleviate disease progression. Yet this disappointing news should not rule out such potential therapies.
| Original language | English |
|---|---|
| Pages (from-to) | 418-420 |
| Number of pages | 3 |
| Journal | Nature |
| Volume | 454 |
| Issue number | 7203 |
| DOIs | |
| State | Published - Jul 24 2008 |